Fatty Acid Regulation of Protein Kinase C Isoforms in Prostate Cancer Cells

By Pandian S.S.   Sneddon A.A.   Bestwick C.S.   McClinton S.   Grant I.   Wahle K.W.J.   Heys S.D.  

Biochemical and Biophysical Research Communications, Vol. 283, Iss. 4, 2001-05 ,pp. : 806-812

Elsevier

Access to resources Recommend Favorite

Toward Inhibitors of Protein Tyrosine Phosphatases for Cancer Treatment

By  

Current Enzyme Inhibition, Vol. 4, Iss. 1, 2008-01 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite

2-5A Ligands - A New Concept for the Treatment of Prostate Cancer

By Cramer Hagen   Okicki James   Rho Taikyun   Wang Xinning   Silverman Robert   Heston Warren  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 10-12, 2007-10 ,pp. : 1471-1477

Taylor & Francis Ltd

Access to resources Recommend Favorite

New progesterone derivatives as inhibitors of 5-reductase enzyme and prostate cancer cell growth

By Cabeza Marisa   Bratoeff Eugene   Heuze Ivonne   Rojas Arely   Terán Nayely   Ochoa Martha'   Teresa Ramírez-Apan Ma   Ramírez Elena   Pérez Victor   Gracia Isabel  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 4, 2006-08 ,pp. : 371-378

Informa Healthcare

Access to resources Recommend Favorite

Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells

By Molinaro Ross J.   Jha Babal Kant   Malathi Krishnamurthy   Varambally Sooryanarayana   Chinnaiyan Arul M.   Silverman Robert H.  

Nucleic Acids Research, Vol. 34, Iss. 22, 2006-12 ,pp. : 6684-6695

Oxford University Press

Access to resources Recommend Favorite